Email Us
View Reports

Global Liposomes Drug Delivery Market Survey and Trends Research | Industry Analysis and Future Forecast 2018 to 2023

  • ID : 1545143890  |  
  • Published : Dec-2017  |  
  • Region : Global  |  
  • Pages : 92   |  
  • Publisher : 99 Strategy

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

Raw Materials

Cost

Technology

Consumer Preference

Industry Overall:

History

Development & Trend

Market Competition

Trade Overview

Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

Regional Market

Production Development

Sales

Regional Trade

Regional Forecast

Company (Johnson & Johnson, Gilead Sciences, Luye Pharma, Sun Pharmaceutical, Fudan-Zhangjiang, Fudan-Zhangjiang, Sigma-Tau Group, Teva Pharmaceutical, CSPC, Novartis, Crucell, Celsion Corporation, Kingond Pharm, Shanghai New Asia, Spectrum Pharmaceuticals etc.):

Company Profile

Product & Service

Business Operation Data

Market Share

Investment Analysis:

Market Features

Investment Opportunity

Investment Calculation

Part 1 Industry Overview

1.1 Liposomes Drug Delivery Industry

1.1.1 Definition

1.1.2 Industry Trend

1.2 Industry Chain

1.2.1 Upstream

1.2.2 Technology

1.2.3 Cost Structure

1.2.4 Consumer Preference

1.2.2 Downstream

Part 2 Industry Overall

2.1 Industry History

2.2 Development Prospect

2.3 Competition Structure

2.4 Relevant Policy

2.5 Trade Overview

Part 3 Liposomes Drug Delivery Market by Product

3.1 Products List of Major Companies

3.2 Market Size

3.3 Market Forecast

4 Key Companies List

4.1 Johnson & Johnson (Company Overview, Sales Data etc.)

4.1.1 Company Overview

4.1.2 Products and Services

4.1.3 Business Analysis

4.2 Gilead Sciences (Company Overview, Sales Data etc.)

4.2.1 Company Overview

4.2.2 Products and Services

4.2.3 Business Analysis

4.3 Luye Pharma (Company Overview, Sales Data etc.)

4.3.1 Company Overview

4.3.2 Products and Services

4.3.3 Business Analysis

4.4 Sun Pharmaceutical (Company Overview, Sales Data etc.)

4.4.1 Company Overview

4.4.2 Products and Services

4.4.3 Business Analysis

4.5 Fudan-Zhangjiang (Company Overview, Sales Data etc.)

4.5.1 Company Overview

4.5.2 Products and Services

4.5.3 Business Analysis

4.6 Fudan-Zhangjiang (Company Overview, Sales Data etc.)

4.6.1 Company Overview

4.6.2 Products and Services

4.6.3 Business Analysis

4.7 Sigma-Tau Group (Company Overview, Sales Data etc.)

4.7.1 Company Overview

4.7.2 Products and Services

4.7.3 Business Analysis

4.8 Teva Pharmaceutical (Company Overview, Sales Data etc.)

4.8.1 Company Overview

4.8.2 Products and Services

4.8.3 Business Analysis

4.9 CSPC (Company Overview, Sales Data etc.)

4.9.1 Company Overview

4.9.2 Products and Services

4.9.3 Business Analysis

4.10 Novartis (Company Overview, Sales Data etc.)

4.10.1 Company Overview

4.10.2 Products and Services

4.10.3 Business Analysis

4.11 Crucell (Company Overview, Sales Data etc.)

4.12 Celsion Corporation (Company Overview, Sales Data etc.)

4.13 Kingond Pharm (Company Overview, Sales Data etc.)

4.14 Shanghai New Asia (Company Overview, Sales Data etc.)

4.15 Spectrum Pharmaceuticals (Company Overview, Sales Data etc.)

Part 5 Market Competition

5.1 Companies Competition

5.2 Industry Competition Structure Analysis

5.2.1 Rivalry

5.2.2 Threat of New Entrants

5.2.3 Substitutes

5.2.4 Bargaining Power of Suppliers

5.2.5 Bargaining Power of Buyers

Part 6 Market Demand by Segment

6.1 Demand Situation

6.1.1 Industry Application Status

6.1.2 Industry SWOT Analysis

6.1.2.1 Strengths

6.1.2.2 Weaknesses

6.1.2.3 Opportunities

6.1.2.4 Threats

6.2 Major Customer Survey

6.3 Demand Forecast

Part 7 Region Operation

7.1 Regional Market

7.2 Production and Sales by Region

7.2.1 Production

7.2.2 Sales

7.2.3 Trade

7.3 Regional Forecast

Part 8 Market Investment

8.1 Market Features

8.1.1 Product Features

8.1.2 Price Features

8.1.3 Channel Features

8.1.4 Purchasing Features

8.2 Investment Opportunity

8.2.1 Regional Investment Opportunity

8.2.2 Industry Investment Opportunity

8.3 Investment Calculation

8.3.1 Cost Calculation

8.3.2 Revenue Calculation

8.3.3 Economic Performance Evaluation

Part 9 Conclusion

Table Global Liposomes Drug Delivery Market 2012-2017, by Type, in USD Million

Table Global Liposomes Drug Delivery Market 2012-2017, by Type, in Volume

Table Global Liposomes Drug Delivery Market Forecast 2018-2023, by Type, in USD Million

Table Global Liposomes Drug Delivery Market Forecast 2018-2023, by Type, in Volume

Table Johnson & Johnson Overview List

Table Liposomes Drug Delivery Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Gilead Sciences Overview List

Table Liposomes Drug Delivery Business Operation of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Luye Pharma Overview List

Table Liposomes Drug Delivery Business Operation of Luye Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sun Pharmaceutical Overview List

Table Liposomes Drug Delivery Business Operation of Sun Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Fudan-Zhangjiang Overview List

Table Liposomes Drug Delivery Business Operation of Fudan-Zhangjiang (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Fudan-Zhangjiang Overview List

Table Liposomes Drug Delivery Business Operation of Fudan-Zhangjiang (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sigma-Tau Group Overview List

Table Liposomes Drug Delivery Business Operation of Sigma-Tau Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Teva Pharmaceutical Overview List

Table Liposomes Drug Delivery Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table CSPC Overview List

Table Liposomes Drug Delivery Business Operation of CSPC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis Overview List

Table Liposomes Drug Delivery Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Crucell Overview List

Table Liposomes Drug Delivery Business Operation of Crucell (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Celsion Corporation Overview List

Table Liposomes Drug Delivery Business Operation of Celsion Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Kingond Pharm Overview List

Table Liposomes Drug Delivery Business Operation of Kingond Pharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Shanghai New Asia Overview List

Table Liposomes Drug Delivery Business Operation of Shanghai New Asia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Spectrum Pharmaceuticals Overview List

Table Liposomes Drug Delivery Business Operation of Spectrum Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Liposomes Drug Delivery Sales Revenue 2012-2017, by Companies, in USD Million

Table Global Liposomes Drug Delivery Sales Revenue Share, by Companies, in USD Million

Table Global Liposomes Drug Delivery Sales Volume 2012-2017, by Companies, in Volume

Table Global Liposomes Drug Delivery Sales Revenue Share, by Companies in 2017, in Volume

Table Liposomes Drug Delivery Demand 2012-2017, by Application, in USD Million

Table Liposomes Drug Delivery Demand 2012-2017, by Application, in Volume

Table Liposomes Drug Delivery Demand Forecast 2018-2023, by Application, in USD Million

Table Liposomes Drug Delivery Demand Forecast 2018-2023, by Application, in Volume

Table Global Liposomes Drug Delivery Market 2012-2017, by Region, in USD Million

Table Global Liposomes Drug Delivery Market 2012-2017, by Region, in Volume

Table Liposomes Drug Delivery Market Forecast 2018-2023, by Region, in USD Million

Table Liposomes Drug Delivery Market Forecast 2018-2023, by Region, in Volume

Figure Liposomes Drug Delivery Industry Chain Structure

Figure Global Liposomes Drug Delivery Market Growth 2012-2017, by Type, in USD Million

Figure Global Liposomes Drug Delivery Market Growth 2012-2017, by Type, in Volume

Figure Global Liposomes Drug Delivery Sales Revenue Share, by Companies in 2017, in USD Million

Figure Global Liposomes Drug Delivery Sales Volume Share 2012-2017, by Companies, in Volume

Figure Production Development by Region

Figure Sales List by Region

Purchase this Market Research Report

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?